Thiazolidin-4-one derivatives

Details Thiazolidin-4-one derivatives Thiazolidin-4-one derivatives

2011-01-25

2011-01-25

Stockton, Laura L. (Department: 1626)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C514S369000

Reexamination Certificate

active

07875726

ABSTRACT:
The invention relates to pharmaceutical compositions containing at least one thiazolidin-4-one derivative to prevent or treat disorders associated with an activated immune system. Furthermore, the invention relates to novel thiazolidin-4-one derivatives notably for use as pharmaceutically active compounds. Said compounds particularly act also as immunosuppressive agents.

REFERENCES:
patent: 2004/0009527 (2004-01-01), Dong et al.
patent: 2004/0167192 (2004-08-01), Solow-Cordero et al.
patent: 2008/0146629 (2008-06-01), Blinkert et al.
patent: 1 219 612 (2002-07-01), None
patent: WO-96/20936 (1996-07-01), None
patent: WO-2004/007491 (2004-01-01), None
Ma, Tonghui et al.; “High-affinity Activators of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Chloride Conductance Identified by High-throughput Screening”; The Journal of Biological Chemistry, vol. 277, No. 40, Issue of Oct. 4, pp. 37235-37241, 2002.
Janusz, John M. et al., “New Cyclooxygenase-2/5-Lipoxygenase Inhibitors. 3. 7-tert-Butyl-2,3-dihydro-3,3-dimethylbenzofuran Derivatives as Gastrointestinal Safe Antiinflammatory and Analgesic Agents: Variations at the 5 Position”; Journal of Medicinal Chemistry, vol. 41, 1998, pp. 3315-3529.
Carter, Percy H. et al.; “Photochemically enhanced binding of small molecules to the tumor necrosis factor receptor-1 inhibits the binding of TNF-α”; Proceedings of the National Academy of Sciences of the United States of America, vol. 98, No. 21, Oct. 9, 2001, pp. 11879-11884.
Berge, Stephen M. et al.; “Pharmaceutical Salts”; Journal of Pharmaceutical Sciences, vol. 66, No. 1, Jan. 1977, pp. 1-19.
Gould, Philip L., et al.; “Salt selection for basic drugs”; International Journal of Pharmaceutics, vol. 33, 1986, pp. 201-217.
Mark Gibson, Editior, Pharmaceutical Preformulation and Formulation, IHS Health Group, Englewood, CO, USA, 2001, Table of Contents Only.
Remington, The Science and Practice of Pharmacy, 20th Edition, Philadelphia College of Pharmacy and Science, Table of Contents Only.
Ehrlenmeyer, et al., CA 37:10142, 1943.

Affiliated with

Also associated with

Rating

Thiazolidin-4-one derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Thiazolidin-4-one derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiazolidin-4-one derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2621021